Voima Ventures has successfully closed its Fund III, which surpasses €100 million and adheres to Article 8 standards.

Inka Mero, the Founder and Managing Partner of Voima Ventures, highlighted the critical role of science-driven entrepreneurship in achieving both global impact and financial returns.

The firm aims to enhance its position as a key partner for early-stage university spinouts and startups in the Nordic and Baltic regions.

Since its inception in 2019, Voima Ventures has prioritized linking academic research with commercial opportunities, with over 70% of its portfolio derived from university spin-offs.

According to the latest Impact Report, Fund III boasts a net impact score of +48%, significantly outperforming the average -8% impact score of US Fortune 500 companies.

Key investors in Fund III include notable entities such as the European Investment Fund, Finnish Tesi, VTT of Finland, Saminvest from Sweden, along with various pension funds and foundations.

The fund plans to make between 25 and 30 investments, having already completed 8 in startups like ÄIO, Liquid Sun, and Avenue Biosciences.

Based in Helsinki and Stockholm, Voima Ventures has focused its investments on advancing deep tech innovations in the Nordic and Baltic regions.

Some of the firm's notable early investments include companies such as Solar Foods, Dispelix, MVision, Betolar, and EniferBio.

Initial investments from Fund III range from €200,000 to €3 million, with opportunities for larger follow-on investments.